The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
α-Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells
Abstract
We have examined the influence of alpha-synuclein on the responsiveness of TSM1 neuronal cells to apoptotic stimulus. We show that alpha-synuclein drastically lowers basal and staurosporine-stimulated caspase 3 immunoreactivity and activity. This is accompanied by lower DNA fragmentation and reduced number of terminal deoxynucleotide transferase-mediated dUTP nick end labeling (TUNEL)-positive neurons. Interestingly, alpha-synuclein also diminishes both p53 expression and transcriptional activity. We demonstrate that the antiapoptotic phenotype displayed by alpha-synuclein can be fully reversed by the Parkinson's disease-associated dopamine derivative 6-hydroxydopamine. Thus, 6-hydroxydopamine fully abolishes the alpha-synuclein-mediated reduction of caspase 3 activity and reverses the associated decrease of p53 expression. 6-Hydroxydopamine triggers thioflavin T-positive deposits in alpha-synuclein, but not mock-transfected TSM1 neurons, and drastically increases alpha-synuclein immunoreactivity. Altogether, we suggest that alpha-synuclein lowers the p53-dependent caspase 3 activation of TSM1 in response to apoptotic stimuli and we propose that the natural toxin 6-hydroxydopamine abolishes this antiapoptotic phenotype by triggering alpha-synuclein aggregation, thereby likely contributing to Parkinson's disease neuropathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“α-Synuclein can decrease p53 expression and transcriptional activity to protect neuronal cells from proapoptotic effectors, in contrast to the A53T mutant form of the protein, which is correlated with PD.222”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [222]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824
β-Synuclein Inhibits α-Synuclein Aggregation
Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., & Masliah, E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00462-7 · Cited by 398
Research works printed but not linked: 37
- Langston, 1998, Ann. Neurol., 44, S45, 10.1002/ana.410440707 · DOI · Paper page
- Shastry, 2001, Neurosci. Res., 41, 5, 10.1016/S0168-0102(01)00254-1 · DOI
- Bogdanovic, 2001, J. Cell. Mol. Med., 5, 318, 10.1111/j.1582-4934.2001.tb00166.x · doi:10.1111/j.1582-4934.2001.tb00166.x
- Spillantini, 1997, Nature, 388, 839, 10.1038/42166 · DOI · Paper page
- Spillantini, 1998, Proc. Natl. Acad. Sci. U. S. A., 95, 6469, 10.1073/pnas.95.11.6469 · DOI · Paper page
- Polymeropoulos, 1997, Science, 276, 2045, 10.1126/science.276.5321.2045 · DOI · Paper page
- Baba, 1998, Am. J. Pathol., 152, 879
- Narhi, 1999, J. Biol. Chem., 274, 9843, 10.1074/jbc.274.14.9843 · DOI · Paper page
- Ostrerova-Golts, 2000, J. Neurosci., 20, 6048, 10.1523/JNEUROSCI.20-16-06048.2000 · DOI · Paper page
- Li, 2001, Biochemistry, 40, 11604, 10.1021/bi010616g · DOI · Paper page
- Giasson, 2002, Neuron, 34, 521, 10.1016/S0896-6273(02)00682-7 · DOI · Paper page
- Anglade, 1997, Histol. Histopathol., 12, 25
- Hirsch, 1999, Mov. Disord., 14, 383, 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F · doi:10.1002/1531-8257(199903)14:2<383::aid-mds1037>3.0.co;2-f
- Alves da Costa, 2000, J. Biol. Chem., 275, 24065, 10.1074/jbc.M002413200 · DOI · Paper page
- Ancolio, 2000, Neurosci. Lett., 285, 79, 10.1016/S0304-3940(00)01049-1 · DOI
- Alves da Costa, 2002, Proc. Natl. Acad. Sci. U. S. A., 99, 4043, 10.1073/pnas.062059899 · DOI
- El-Deiry, 1993, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
- Soto-Otero, 2000, J. Neurochem., 74, 1605, 10.1046/j.1471-4159.2000.0741605.x · DOI · Paper page
- Kim, 2002, Free Radic. Biol. Med., 32, 544, 10.1016/S0891-5849(02)00741-4 · DOI
- Kholodilov, 1999, J. Neurochem., 73, 2586, 10.1046/j.1471-4159.1999.0732586.x · DOI
- Kholodinov, 1999, Neurosci. Lett., 275, 105, 10.1016/S0304-3940(99)00740-5 · DOI
- Lee, 2001, J. Neurochem., 76, 998, 10.1046/j.1471-4159.2001.00149.x · DOI · Paper page
- Hashimoto, 2002, J. Biol. Chem., 277, 11465, 10.1074/jbc.M111428200 · DOI · Paper page
- Roperch, 1998, Nature Medicine, 4, 835, 10.1038/nm0798-835 · DOI · Paper page
- Masliah, 2000, Science, 287, 1265, 10.1126/science.287.5456.1265 · DOI · Paper page
- van der Putten, 2000, J. Neurosci., 20, 6021, 10.1523/JNEUROSCI.20-16-06021.2000 · DOI · Paper page
- Suh, 2002, Pharmacol. Rev., 54, 469, 10.1124/pr.54.3.469 · DOI · Paper page
- Alves da Costa, C. (2002) Curr. Mol. Med., in press
- Sauer, 1994, Neuroscience, 59, 401, 10.1016/0306-4522(94)90605-X · DOI · Paper page
- Przedborski, 1995, Neuroscience, 67, 631, 10.1016/0306-4522(95)00066-R · DOI · Paper page
- Tillerson, 2001, J. Neurosci., 21, 4427, 10.1523/JNEUROSCI.21-12-04427.2001 · DOI · Paper page
- Cass, 2002, Brain Res., 938, 29, 10.1016/S0006-8993(02)02481-2 · DOI
- Curtius, 1974, J. Chromatogr., 99, 529, 10.1016/S0021-9673(00)90882-3 · DOI
- Jellinger, 1995, J. Neural. Transm., 46, 297
- Riobo, 2002, Free Radic. Biol. Med., 32, 115, 10.1016/S0891-5849(01)00758-4 · DOI
- Xu, 2002, Nat. Med., 8, 600, 10.1038/nm0602-600 · DOI · Paper page
- Chun, 1996, Mol. Cell. Neurosci., 7, 304, 10.1006/mcne.1996.0023 · DOI
Cited by
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
Zhou, W., & Freed, C. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507124200 · Cited by 346
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0309-3 · Cited by 287
Metadata
- Authors
- Alves da Costa, C., Paitel, E., Vincent, B., & Checler, F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50980-50984
- ISSN
- 0021-9258
- Cited by
- 122
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6528 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.